Клаус Кёнлейн - Вирусомания

190 Ibid., pp. 144 - 145

191 About EIS, Website der Epidemic Intelligence Service, see www.cdc.gov/eis/about/about.htm

192 Alumni, Website der Epidemic Intelligence Service, see www.cdc.gov/eis/alurnni/alumni.htm

193 Epstein, Steven, Impure Science-AIDS, Activism and the Politics of Knowledge, University of California Press, 1996, p. 72

194 Koch, Klaus, 1st Europa jetzt vor Seuchen sicher?, Interview mit Hans Wigzell vom Karoliska-Institut in Stockholm, Siiddeutsche Zeitung, 22 March 2005, p. 10

195 Duesberg, Peter, Inventing the AIDS Virus, Regnery Publishing, 1996, pp. 135 - 136

196 Cohen, Jon, Doing Science in the Spotlight's Glare, Science, 1992, Vol. 257, p. 1033

197 Noelle-Neumann, Elisabeth, Die Schweigespirale: Offentliche Meinung-unsere soziale Haut, Langen Muller,

2001, p. 322

198 Epstein, Steven, Impure Science-AIDS, Activism and the Politics of Knowledge, University of California Press, 1996, pp. 105 - 106

199 Celia Farber, AIDS: Words from the Front, Spin, January 1988, pp. 43 - 44, 73

200 Penning, Randolph, Priivalenz der HIV-Infektion bei gerichtlich Obduzierten und speziell Drogentoten am Institut fur Rechtsmedizin der Universitiit Miinchen von 1985 bis 1988, AIDSForschung, 4/1989, pp. 459-465

201 Booth, William, A Rebel without a cause of AIDS, Science, 25 March 1988, p. 1485

202 Epstein, Steven, Impure Science-AIDS, Activism and the Politics of Knowledge, University of California Press, 1996, p. 113

203 see www.virusmyth.net/AIDS/indeX/cthomas.htm

204 Hodgkinson, Neville, AIDS: Can We Be Positive?, Sunday Times (London), 26 April 1992

205 Duesberg, Peter, Inventing the AIDS Virus, Regnery Publishing, 1996, p. 244

206 Rapoport, Ron, AIDS: The Unanswered Questions, Oakland Tribune, 22 May 1989, pp. A1 - A2

207 Duesberg, Peter, Inventing the AIDS Virus, Regnery Publishing, 1996, p. 237

208 Boffey, Phillip, A Solitary Dissenter Disputes Cause of AIDS, New York Times, 12 January 1988, p. C-3

209 France, David, The HIV Disbelievers, Newsweek, 19 August 2000

210 "Filtern und zensieren," Interview with John Maddox, Der Spiegel, 7 November 1994, p. 229

211 Letter from John Maddox to Claus KueHIVlein, 20 September 1995

212 Ho, David, Rapid turnover of plasma virions and CD4 lymphocytes in HIV- 1 infection, Nature, 12 January 1995, pp. 123 - 126

213 Craddock, Mark, H IV: Science by press conference, in: AIDS: Virus- or Drug Induced? by Peter Duesberg (Ed.), Kluwer Academic Publishers, 1996, pp. 127 - 130

214 Tahi, Djamel, AIDS-die groBen Zweifel, Arte Television, 14 March 1996, see www.torstenengelbrecht.com/de/artikel _ medien.html

215 Langbein, Kurt; Ehgartner, Bert, Das Medizinkartell: Die sieben Todsiinden der Gesundheitsindustrie, Piper,

2003, p. 347

216 Wolthers, Katja, T Cell Telomere Length in HIV- 1 Infection: No Evidence for increased CD4+ T Cell Turnover, Science, 29. November 1996, pp. 1543 - 1547

217 Engelbrecht, Torsten, Sex, Blut und Tod, "HIV verursacht AIDS." An der Verfestigung dieses Theorems liisst sich zeigen, wie der Wissenschafrs-Journalismus folgenreiche Widerspriiche ausblendet und Zweifel wegdriickt, Message, 1/2005, pp. 41 - -42

218 Cimons, Marlene, Bad Blood Two Groups of AIDS Researchers-One American, One French-Are Fighting More Than Just the Disease, Los Angeles Times, 25 May 1986, p. 16

219 Remnick, David, Robert Gallo Goes To War, Washington Post, 9 August 1987, W 10

220 Der lang erwartete Messias, tageszeitung, 24 December 1996, p. 11

221 Hoffmann, Christian, ART 2004. Historie, see hiv.net/2010/haart.htm

222 Chua-Eoan, How'!-fd, 1996: David Ho, TIME, 30 December 1996

223 Lawrence, Altman, US Panel seeks Changes in Treatment of AIDS Virus, New York Times, 4 February, 2001

224 Berndt, Christina, Da-I, der Grage, hat sich geirn, Siiddeutsche Zeitung, 27 January 2004

225 Grolle, Johann, Sieg iiber die Seuche?, Der Spiegel, 2/1997

226 Connolly, Ceci, States Offering Less Assistance For AIDS Drugs, Washington Post, 20 May 2004, p. A04

227 Personal phone interview with Hans Halter

228 Prange, Astrid, Hoffnung kostet 140 Dollar, Rheinischer Merkur, 48/2005, p. 14

229 AIDS ist behandelbar, Schleswig-Ho/steinisches Arzteblatt, 2!2000, pp. 14 - 15

230 AIDS Drugs extend Survival Times Fourfold, Reuters NewMedia, 14 March 2001

231 Kohnlein, Claus, Die groge Illusion. Das Dilemma der antiretroviralen Therapie/HAART aus einem kritischen Blickwinkel, see www.rethinkingaids.de/allg/koenl-2.htm

232 Duesberg, Peter, Inventing the AIDS Virus, Regnery Publishing, 1996, p. 425

233 Duesberg, Peter; KoeHIVlein, Claus; Rasnick, David, The Chemical Bases of the Various AIDS Epidemics: Recreational Drugs, Anti-viral Chemotherapy and Malnutrition, Journal of Biosciences, June 2003, p. 402

234 Coghlan, Andy, Bid to solve riddle of 'natural resistance' to HIV, New Scientist, 15 August 2006

235 Duesberg, Peter, Inventing the AIDS Virus, Regnery Publishing, 1996, p. 425

236 Kohnlein, Claus, Die groge Illusion. Das Dilemma der antiretroviralen Therapie/HAART aus einem kritischen Blickwinkel, see www.rethinkingaids.de/allg!koenl-2.htm

237 HIV/AIDS-files, Roben Koch Institute, June 2003

238 Fleming, Thomas; DeMers, David, Surrogate end points in clinical trials: are we being misled? Annals of Internal Medicine, 1 October 1996, pp. 605 - 613

239 Revision Of The Surveillance Case Definition For AIDS In Canada, in: Canada Communicable Disease Repon, Health and Welfare Canada, 15 December 1993, p. 196

240 Koliadin, Vladimir, Some Facts behind de Expansion of the Definition of AIDS in 1993, March 1998; see www.virusmyth.net/aids/data/vknewdef.htm

241 CASCADE (Concened Action on SeroConversion to AIDS and Death in Europe) Collaboration, Determinants of survival following HIV-1 seroconversion after the introduction of HAART, Lancet, 18 October 2003, pp. 1267 - 1274

242 Suspension of Disbelief? ? , Health Education AIDS Liaison (HEAL), Toronto, http://healtoronto.com/aidsdrop.html

243 HIV treatment response and prognosis in Europe and Nonh America in the first decade of highly active antiretroviral therapy: a collaborative analysis, Lancet, 5 August 2006, pp. 451 - 458

244 New Studies Shake AIDS World . . . and more interesting news from Alive & Well, news release from Christine Maggiore/ Alive & Well, 30 November 2006

245 Fischl, Margaret, The toxicity of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex. A double-blind, placebo-controlled trial, New England Journal of Medicine, 23 July 1987, pp. 192 - 197

246 Law, Jacky, Big Pharma. How the world's biggest drug companies market illness, Constable & Robinson, 2006

247 The fool's gold that heals, Guardian, 14 January 2006

248 Temple, Roben, Placebo-Controlled Trials and Active-Control Trials in the Evaluation of New Treatments. Pan 1: Ethical and Scientific Issues, Annals of Internal Medicine, 19 September 2000, pp. 455 - 463

249 Ellenberg, Susan, Placebo-Controlled Trials and Active-Control Trials in the Evaluation of New Treatments. Pan 2: Practical Issues and Specific Cases, Annuals of Internal Medicine, 19 September 2000, pp. 464 - 470

250 Evans, David ; Smith, Mike; Willen, Liz, Drug Industry Human Testing Masks Death, Injury, Compliant FDA, Bloomberg.com, 2 November 2005

251 Sharav, Vera, New Evidence Uncovered About AIDS Drug/Vaccine Experiments on Foster Care Infants &

Children, Alliance for Human Research Protection, 1 September 2005

252 Scheff, Liam, The House that AIDS built, see www.altheal.org/toxicity/house.htm

253 Montero, Douglas, AIDS Tots Used As 'Guinea Pigs,' New York Post, 29 February 2004, p. 1

254 Doran, Jamie, Guinea Pig Kids, 30 November 2004